Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -43.09%-673K | 49.68%-292.01K | 47.34%-369.73K | 31.13%-2.19M | 31.94%-434.67K | 28.79%-470.34K | 68.10%-580.31K | -1,111.80%-702.09K | 41.02%-3.18M | 54.02%-638.62K |
| Net income from continuing operations | -9.31%-558.82K | 25.89%-443.64K | 30.20%-499.89K | 26.66%-2.33M | 51.40%-500.69K | -6.19%-511.24K | 41.69%-598.61K | -12.88%-716.18K | 50.26%-3.17M | 23.95%-1.03M |
| Depreciation and amortization | -24.68%25.93K | -24.69%25.93K | -24.68%25.93K | -14.46%137.69K | -14.46%34.42K | -14.46%34.42K | -14.45%34.42K | -14.46%34.42K | -35.50%160.96K | -36.58%40.24K |
| Remuneration paid in stock | --0 | -54.82%1.84K | -53.70%2.3K | -88.65%16.9K | -97.32%3.72K | --4.12K | --4.08K | -50.30%4.98K | 27.38%148.92K | 1,139.90%138.91K |
| Change In working capital | -6,069.71%-140.11K | 713.19%123.87K | 502.67%101.93K | 95.12%-15.29K | -86.87%27.87K | 101.07%2.35K | 97.57%-20.2K | -104.81%-25.31K | -150.06%-313.44K | 294.83%212.36K |
| -Change in receivables | -152.19%-3.02K | 6.51%7K | -196.12%-4.63K | -72.38%14.44K | 81.96%-2.74K | -74.92%5.78K | 185.42%6.58K | -90.75%4.82K | -77.61%52.27K | 32.01%-15.19K |
| -Change in payables and accrued expense | -1,840.18%-129.22K | 265.72%78.76K | 522.68%122.75K | 94.32%-19.4K | -73.73%63.83K | 97.27%-6.66K | 94.07%-47.53K | -106.30%-29.04K | -200.94%-341.51K | 472.91%242.96K |
| -Change in other current assets | -344.14%-7.88K | 83.57%38.1K | -1,377.72%-16.18K | 57.30%-10.33K | -115.48%-33.22K | 79.72%3.23K | 186.83%20.75K | -108.22%-1.1K | -144.47%-24.2K | 28.32%-15.42K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -43.09%-673K | 49.68%-292.01K | 47.34%-369.73K | 31.13%-2.19M | 31.94%-434.67K | 28.79%-470.34K | 68.10%-580.31K | -1,111.80%-702.09K | 41.02%-3.18M | 54.02%-638.62K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 98.13%-1.6K | 0 | |||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 98.13%-1.6K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 98.13%-1.6K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 137.56K | 9.87%1.66M | 293.15K | -59.71%1.51M | 0 | 0 | 1.51M | 0 | 37.91%3.75M | -108.44%-97.38K |
| Net common stock issuance | --137.56K | 9.87%1.66M | --293.15K | -59.73%1.51M | --0 | --0 | --1.51M | --0 | 39.81%3.75M | -108.85%-97.38K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -104.75%-1.7K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --137.56K | 9.87%1.66M | --293.15K | -59.71%1.51M | --0 | --0 | --1.51M | --0 | 37.91%3.75M | -108.44%-97.38K |
| Net cash flow | ||||||||||
| Beginning cash position | 36.68%1.44M | -40.93%73.03K | -81.88%149.61K | 226.84%825.74K | -62.59%584.28K | -52.54%1.05M | -36.50%123.65K | 226.84%825.74K | -91.59%252.65K | 285.09%1.56M |
| Current changes in cash | -13.84%-535.44K | 46.98%1.37M | 89.09%-76.58K | -217.98%-676.13K | 40.94%-434.67K | 28.79%-470.34K | -54.08%930.98K | -1,111.80%-702.09K | 120.83%573.09K | -381.33%-736K |
| End cash Position | 55.06%905.98K | 36.68%1.44M | -40.93%73.03K | -81.88%149.61K | -81.88%149.61K | -62.59%584.28K | -52.54%1.05M | -36.50%123.65K | 226.84%825.74K | 226.84%825.74K |
| Free cash from | -43.09%-673K | 49.68%-292.01K | 47.34%-369.73K | 31.17%-2.19M | 31.94%-434.67K | 28.79%-470.34K | 68.13%-580.31K | -1,111.80%-702.09K | 41.92%-3.18M | 51.14%-638.62K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.